InMed Pharmaceuticals Inc. (MTRI) shareholders
MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM
$15.61+3.41 (+27.94%)
Close on Nov 11, 2026Market cap $85.75MP/E –Yield –
Ownership
Who owns InMed Pharmaceuticals's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
50 buys · 0 sales
Net bought $1.40M
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Daniel Schneeberger Joint filing with ADAR1 Capital Management, LLC (17.20%) | 943,668 | 17.20% | 13G (passive) amendment | Sep 30, 2026 |
| Vivo Opportunity Fund Holdings, L.P. Joint filing with Vivo Opportunity, LLC (21.70%) | 718,444 | 21.70% | 13D (active) | May 19, 2026 |
| William Blank Joint filing with Squadron Master Fund LP (9.80%), Squadron Capital Management LLC (9.80%) and 1 more | 325,000 | 9.80% | 13G (passive) | May 19, 2026 |
| Sabby Volatility Warrant Master Fund, Ltd. Joint filing with Sabby Management, LLC (9.90%), Hal Mintz (9.90%) | 280,138 | 9.90% | 13G (passive) | Dec 31, 2025 |
| YA II PN, Ltd. Joint filing with YA Global Investments II (U.S.), LP (9.99%), Yorkville Advisors Global, LP (9.99%) and 5 more | 80,372 | 9.99% | 13G (passive) | Dec 13, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Eric A. Adams | President & CEO, Director | 58,894 | Dec 19, 2025 |
| Netta Jagpal | Chief Financial Officer | – | Dec 19, 2025 |
| Shane Aaron Johnson | Sr VP & General Manager | 583,023 | Dec 19, 2025 |
| Michael Woudenberg | Chief Operating Officer | 530 | Dec 19, 2025 |
| Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | 1,273 | Dec 19, 2025 |
| John Steven Bathery | Director | – | Dec 19, 2025 |
| Andrew Hull | Director | 38,258 | Dec 19, 2025 |
| Nicole Lemerond | Director | – | Dec 19, 2025 |
| Neil A. Klompas | Director | – | Dec 19, 2025 |
| Janet P. Grove | Director | – | Dec 23, 2024 |
| Bryan T. Baldasare | Director | – | Dec 23, 2024 |
| ADAR1 Capital Management, LLC | 10% owner | 98,297 | Nov 9, 2026 |
| Daniel Schneeberger | 10% owner | 892,101 | Nov 9, 2026 |
| Vivo Opportunity Fund Holdings, L.P. | 10% owner | 541,752 | Jul 16, 2026 |
| Vivo Opportunity Cayman, LLC | 10% owner | – | Jul 16, 2026 |
| Vivo Opportunity, LLC | 10% owner | 797,530 | Jul 16, 2026 |
| Vivo Opportunity Cayman Fund, L.P. | 10% owner | 818,076 | Jul 16, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC 10% owner | Nov 5, 2026 | Buy | +2,640 | $13.10 | $34.57K | 98,297 |
| ADAR1 Capital Management, LLC 10% owner | Oct 23, 2026 | Buy | +4 | $1.32 | $5 | 956,584 |
| ADAR1 Capital Management, LLC 10% owner | Oct 19, 2026 | Buy | +1,086 | $1.32 | $1.43K | 956,580 |
| ADAR1 Capital Management, LLC 10% owner | Oct 16, 2026 | Buy | +1 | $1.32 | $1 | 955,494 |
| ADAR1 Capital Management, LLC 10% owner | Oct 15, 2026 | Buy | +984 | $1.32 | $1.30K | 955,493 |
| ADAR1 Capital Management, LLC 10% owner | Oct 14, 2026 | Buy | +8,021 | $1.33 | $10.67K | 954,509 |
| ADAR1 Capital Management, LLC 10% owner | Oct 13, 2026 | Buy | +564 | $1.33 | $750 | 946,488 |
| ADAR1 Capital Management, LLC 10% owner | Oct 8, 2026 | Buy | +2,256 | $1.33 | $3.00K | 945,924 |
| ADAR1 Capital Management, LLC 10% owner | Oct 7, 2026 | Buy | +3,046 | $1.33 | $4.05K | 943,668 |
| ADAR1 Capital Management, LLC 10% owner | Oct 6, 2026 | Buy | +5,601 | $1.33 | $7.44K | 940,622 |
| ADAR1 Capital Management, LLC 10% owner | Oct 5, 2026 | Buy | +18,182 | $1.33 | $24.18K | 935,021 |
| ADAR1 Capital Management, LLC 10% owner | Oct 2, 2026 | Buy | +8,307 | $1.33 | $11.05K | 916,839 |
| ADAR1 Capital Management, LLC 10% owner | Oct 1, 2026 | Buy | +16,431 | $1.33 | $21.85K | 908,532 |
| Daniel Schneeberger 10% owner | Sep 16, 2026 | Buy | +8,340 | $1.29 | $10.76K | 892,101 |
| Daniel Schneeberger 10% owner | Sep 15, 2026 | Buy | +54,256 | $1.30 | $70.53K | 883,761 |
| Daniel Schneeberger 10% owner | Sep 14, 2026 | Buy | +28,505 | $1.29 | $36.77K | 829,505 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 16, 2026 | Buy | +19 | $1.55 | $29 | 743,057 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 16, 2026 | Buy | +2 | $1.55 | $3 | 75,019 |
| ADAR1 Capital Management, LLC 10% owner | Jul 15, 2026 | Buy | +1,000 | $1.56 | $1.56K | 801,000 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 15, 2026 | Buy | +13,761 | $1.55 | $21.33K | 743,038 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 15, 2026 | Buy | +1,389 | $1.55 | $2.15K | 75,017 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 14, 2026 | Buy | +4,882 | $1.55 | $7.57K | 729,277 |
| Vivo Opportunity Cayman Fund, L.P. 10% owner | Jul 14, 2026 | Buy | +493 | $1.55 | $764 | 73,628 |
| Vivo Opportunity, LLC 10% owner | Jul 2, 2026 | Buy | +1,460 | $1.55 | $2.26K | 724,395 |
| Vivo Opportunity, LLC 10% owner | Jul 2, 2026 | Buy | +147 | $1.55 | $228 | 73,135 |
| Vivo Opportunity, LLC 10% owner | Jul 1, 2026 | Buy | +3,946 | $1.55 | $6.12K | 722,935 |
| Vivo Opportunity, LLC 10% owner | Jul 1, 2026 | Buy | +398 | $1.55 | $617 | 72,988 |
| Vivo Opportunity, LLC 10% owner | Jun 30, 2026 | Buy | +55 | $1.54 | $85 | 72,590 |
| Vivo Opportunity, LLC 10% owner | Jun 30, 2026 | Buy | +545 | $1.54 | $839 | 718,989 |
| Vivo Opportunity, LLC 10% owner | Jun 8, 2026 | Buy | +29,518 | $1.52 | $44.87K | 718,444 |
| Vivo Opportunity, LLC 10% owner | Jun 8, 2026 | Buy | +2,982 | $1.52 | $4.53K | 72,535 |
| Vivo Opportunity, LLC 10% owner | Jun 5, 2026 | Buy | +5,045 | $1.57 | $7.92K | 69,553 |
| Vivo Opportunity, LLC 10% owner | Jun 5, 2026 | Buy | +49,966 | $1.57 | $78.45K | 688,926 |
| Vivo Opportunity, LLC 10% owner | Jun 4, 2026 | Buy | +618 | $1.57 | $970 | 64,508 |
| Vivo Opportunity, LLC 10% owner | Jun 4, 2026 | Buy | +6,125 | $1.57 | $9.62K | 638,960 |
| Vivo Opportunity, LLC 10% owner | Jun 3, 2026 | Buy | +714 | $1.55 | $1.11K | 63,890 |
| Vivo Opportunity, LLC 10% owner | Jun 3, 2026 | Buy | +7,069 | $1.55 | $10.96K | 632,835 |
| Vivo Opportunity, LLC 10% owner | Jun 2, 2026 | Buy | +2,095 | $1.52 | $3.18K | 63,176 |
| Vivo Opportunity, LLC 10% owner | Jun 2, 2026 | Buy | +20,753 | $1.52 | $31.54K | 625,766 |
| Vivo Opportunity, LLC 10% owner | Jun 1, 2026 | Buy | +1,498 | $1.55 | $2.32K | 61,081 |
| Vivo Opportunity, LLC 10% owner | Jun 1, 2026 | Buy | +14,838 | $1.55 | $23.00K | 605,013 |
| Vivo Opportunity, LLC 10% owner | May 29, 2026 | Buy | +1,632 | $1.57 | $2.56K | 59,583 |
| Vivo Opportunity, LLC 10% owner | May 29, 2026 | Buy | +16,164 | $1.57 | $25.38K | 590,175 |
| Vivo Opportunity, LLC 10% owner | May 21, 2026 | Buy | +3,118 | $1.69 | $5.27K | 57,951 |
| Vivo Opportunity, LLC 10% owner | May 21, 2026 | Buy | +30,882 | $1.69 | $52.19K | 574,011 |
| Vivo Opportunity, LLC 10% owner | May 20, 2026 | Buy | +5,154 | $1.56 | $8.04K | 54,833 |
| Vivo Opportunity, LLC 10% owner | May 20, 2026 | Buy | +51,056 | $1.56 | $79.65K | 543,129 |
| Daniel Schneeberger 10% owner | May 19, 2026 | Buy | +200,000 | $1.50 | $300.00K | 800,000 |
| Daniel Schneeberger 10% owner | May 19, 2026 | Buy | +200,000 | $1.56 | $312.00K | 600,000 |
| Daniel Schneeberger 10% owner | May 19, 2026 | Buy | +68,551 | $1.60 | $109.68K | 400,000 |
| Alexandra Diane Janet Mancini – | Jul 31, 2024 | Sale | −240 | $0.18 | $43 | 0 |
| Andrew Hull Director | Feb 21, 2024 | Buy | +37,500 | $0.39 | $14.63K | 38,258 |
| Eric A. Adams President & CEO, Director | Feb 20, 2024 | Buy | +41,600 | $0.36 | $14.98K | 43,959 |
| Eric A. Adams President & CEO, Director | Apr 14, 2022 | Buy | +14,160 | $0.89 | $12.60K | 59,003 |
| Eric A. Adams President & CEO, Director | Apr 13, 2022 | Buy | +8,560 | $0.85 | $7.28K | 44,843 |
| Bruce Colwill CFO | Jan 24, 2022 | Buy | +5,000 | $1.09 | $5.45K | 11,515 |
| Shane Aaron Johnson SVP, GM of BayMedica LLC | Jan 6, 2022 | Buy | +8,500 | $1.26 | $10.71K | 304,595 |
| Shane Aaron Johnson SVP, GM of BayMedica LLC | Dec 30, 2021 | Buy | +8,093 | $1.33 | $10.76K | 296,095 |
| Shane Aaron Johnson SVP, GM of BayMedica LLC | Nov 15, 2021 | Buy | +5,000 | $1.37 | $6.85K | 288,002 |
| Eric A. Adams President & CEO, Director | Sep 29, 2021 | Buy | +8,800 | $1.73 | $15.22K | 36,283 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
See a number that looks wrong?